Literature DB >> 21402716

Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation.

Erin E Matthews1, Damien Thévenin, Julia M Rogers, Lisa Gotow, Paul D Lira, Lawrence A Reiter, William H Brissette, Donald M Engelman.   

Abstract

We report how rotational variations in transmembrane (TM) helix interactions participate in the activity states of the thrombopoietin receptor (TpoR), a type 1 cytokine receptor that controls the production of blood platelets. We also explore the mechanism of small-molecule agonists that do not mimic the natural ligand. We show, by a combination of cysteine cross-linking, alanine-scanning mutagenesis, and computational simulations, that the TpoR TM dimerizes strongly and can adopt 3 different stable, rotationally related conformations, which may correspond to specific states of the full-length receptor (active, inactive, and partially active). Thus, our data suggest that signaling and inactive states of the receptor are related by receptor subunit rotations, rather than a simple monomer-dimer transition. Moreover, results from experiments with and without agonists in vitro and in cells allow us to propose a novel allosteric mechanism of action for a class of small molecules, in which they activate TpoR by binding to the TM region and by exploiting the rotational states of the dimeric receptor. Overall, our results support the emerging view of the participation of mutual rotations of the TM domains in cytokine receptor activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402716      PMCID: PMC3114528          DOI: 10.1096/fj.10-178673

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  46 in total

1.  The interface between self-assembling erythropoietin receptor transmembrane segments corresponds to a membrane-spanning leucine zipper.

Authors:  Weiming Ruan; Verena Becker; Ursula Klingmüller; Dieter Langosch
Journal:  J Biol Chem       Date:  2003-11-05       Impact factor: 5.157

2.  Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 1. Discovery and optimization of salicylaldehyde thiosemicarbazone thrombopoietin mimics.

Authors:  Kevin J Duffy; Anthony N Shaw; Evelyne Delorme; Susan B Dillon; Connie Erickson-Miller; Leslie Giampa; Yifang Huang; Richard M Keenan; Peter Lamb; Nannan Liu; Stephen G Miller; Alan T Price; Jon Rosen; Heather Smith; Kenneth J Wiggall; Lihua Zhang; Juan I Luengo
Journal:  J Med Chem       Date:  2002-08-15       Impact factor: 7.446

3.  Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains.

Authors:  Xiaohui Lu; Alec W Gross; Harvey F Lodish
Journal:  J Biol Chem       Date:  2006-01-12       Impact factor: 5.157

4.  Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor.

Authors:  K F Kubatzky; W Ruan; R Gurezka; J Cohen; R Ketteler; S S Watowich; D Neumann; D Langosch; U Klingmüller
Journal:  Curr Biol       Date:  2001-01-23       Impact factor: 10.834

5.  Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.

Authors:  J G Drachman; K Kaushansky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Hydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis.

Authors:  K J Duffy; M G Darcy; E Delorme; S B Dillon; D F Eppley; C Erickson-Miller; L Giampa; C B Hopson; Y Huang; R M Keenan; P Lamb; L Leong; N Liu; S G Miller; A T Price; J Rosen; R Shah; T N Shaw; H Smith; K C Stark; S S Tian; C Tyree; K J Wiggall; L Zhang; J I Luengo
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

7.  The identification of orally bioavailable thrombopoietin agonists.

Authors:  Michael J Munchhof; Amy S Antipas; Laura C Blumberg; William H Brissette; Matthew F Brown; Jeffrey M Casavant; Jonathan L Doty; James Driscoll; Thomas M Harris; Lilli A Wolf-Gouveia; Christopher S Jones; Qifang Li; Robert G Linde; Paul D Lira; Anthony Marfat; Eric McElroy; Mark Mitton-Fry; Sandra P McCurdy; Lawrence A Reiter; Sharon L Ripp; Andrei Shavnya; Lisa M Thomasco; Kristen A Trevena
Journal:  Bioorg Med Chem Lett       Date:  2009-01-15       Impact factor: 2.823

Review 8.  New thrombopoietic growth factors.

Authors:  David J Kuter
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

9.  A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis.

Authors:  Takanori Nakamura; Yoshitaka Miyakawa; Atsushi Miyamura; Akiko Yamane; Hidenori Suzuki; Mamoru Ito; Yasuyuki Ohnishi; Norihisa Ishiwata; Yasuo Ikeda; Nobutomo Tsuruzoe
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

10.  Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.

Authors:  Nadine Seubert; Yohan Royer; Judith Staerk; Katharina F Kubatzky; Virginie Moucadel; Shyam Krishnakumar; Steven O Smith; Stefan N Constantinescu
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

View more
  31 in total

1.  Orientation-specific signalling by thrombopoietin receptor dimers.

Authors:  Judith Staerk; Jean-Philippe Defour; Christian Pecquet; Emilie Leroy; Hélène Antoine-Poirel; Ian Brett; Miki Itaya; Steven O Smith; William Vainchenker; Stefan N Constantinescu
Journal:  EMBO J       Date:  2011-09-02       Impact factor: 11.598

Review 2.  Juxtamembrane contribution to transmembrane signaling.

Authors:  Wei Deng; Renhao Li
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

3.  An unusual, activating insertion/deletion MPL mutant in primary myelofibrosis.

Authors:  J-P Defour; Y Hoade; A-M Reuther; A Callaway; D Ward; F Chen; S N Constantinescu; N C P Cross
Journal:  Leukemia       Date:  2017-05-22       Impact factor: 11.528

4.  Mutations in Escherichia coli ExbB transmembrane domains identify scaffolding and signal transduction functions and exclude participation in a proton pathway.

Authors:  Kristin R Baker; Kathleen Postle
Journal:  J Bacteriol       Date:  2013-04-19       Impact factor: 3.490

5.  Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.

Authors:  Stephan Wilmes; Maximillian Hafer; Joni Vuorio; Julie A Tucker; Hauke Winkelmann; Sara Löchte; Tess A Stanly; Katiuska D Pulgar Prieto; Chetan Poojari; Vivek Sharma; Christian P Richter; Rainer Kurre; Stevan R Hubbard; K Christopher Garcia; Ignacio Moraga; Ilpo Vattulainen; Ian S Hitchcock; Jacob Piehler
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

6.  An auto-inhibitory helix in CTP:phosphocholine cytidylyltransferase hijacks the catalytic residue and constrains a pliable, domain-bridging helix pair.

Authors:  Mohsen Ramezanpour; Jaeyong Lee; Svetla G Taneva; D Peter Tieleman; Rosemary B Cornell
Journal:  J Biol Chem       Date:  2018-03-08       Impact factor: 5.157

7.  His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor.

Authors:  Emilie Leroy; Jean-Philippe Defour; Takeshi Sato; Sharmila Dass; Vitalina Gryshkova; Myat M Shwe; Judith Staerk; Stefan N Constantinescu; Steven O Smith
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

8.  Duplicated TLR5 of zebrafish functions as a heterodimeric receptor.

Authors:  Carlos G P Voogdt; Jaap A Wagenaar; Jos P M van Putten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

9.  Screening for transmembrane association in divisome proteins using TOXGREEN, a high-throughput variant of the TOXCAT assay.

Authors:  Claire R Armstrong; Alessandro Senes
Journal:  Biochim Biophys Acta       Date:  2016-07-22

10.  Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation.

Authors:  Jean-Philippe Defour; Miki Itaya; Vitalina Gryshkova; Ian C Brett; Christian Pecquet; Takeshi Sato; Steven O Smith; Stefan N Constantinescu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.